• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视神经脊髓炎谱系疾病伴发脊髓炎病史的患者长期残疾与发病年龄、诊断/预防治疗延迟、MRI 病变长度和症状性脑病变存在有关。

Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.

机构信息

Johns Hopkins University, School of Medicine, Department of Neurology, Baltimore, MD, USA; Johns Hopkins University School of Nursing, Baltimore, MD, USA.

Johns Hopkins University School of Nursing, Baltimore, MD, USA.

出版信息

Mult Scler Relat Disord. 2019 Feb;28:64-68. doi: 10.1016/j.msard.2018.12.011. Epub 2018 Dec 9.

DOI:10.1016/j.msard.2018.12.011
PMID:30554040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6397677/
Abstract

BACKGROUND

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disease of the central nervous system (CNS) that preferentially targets the spinal cord and optic nerves. Increasing disability is accrued with each inflammatory attack. Disability has been shown to be an independent predictor of poor quality of life in those with NMOSD. Factors associated with increasing disability need further systematic investigation.

METHODS

We performed a multi-center retrospective chart analysis of aquaporin-4 (AQP4) seropositive NMOSD patients with a history of myelitis seen at five large referral centers for patients with NMOSD worldwide for whom thorough records including relapse history and corresponding imaging were available. Potential contributors to long-term disability were extracted including demographics, radiographic findings, and clinical characteristics. Multivariable regression modeling was conducted to determine correlates of disability in patients with NMOSD, as measured by the Expanded Disability Status Scale (EDSS).

RESULTS

One hundred eighty-two AQP4 seropositive patients (88% female) were included in this analysis. Multiple regression modeling revealed that older age at disease onset, delay in diagnosis/preventive treatment, length of longest acute myelitis lesion and presence of symptomatic brain/brainstem lesions were associated with increased disability when holding other variables constant.

CONCLUSION

While age at onset is a factor that cannot be controlled in NMOSD, we can reduce the delay in diagnosis/preventive treatment and reduce future relapses in the brain/brainstem and spinal cord. Delay in diagnosis/preventive treatment and imaging variables that contributed to increased disability support the need for improved measures for early, accurate diagnosis and management of NMOSD, and aggressive treatment of acute relapses.

摘要

背景

视神经脊髓炎谱系疾病(NMOSD)是一种中枢神经系统(CNS)自身免疫性疾病,优先靶向脊髓和视神经。每次炎症发作都会增加残疾程度。残疾已被证明是 NMOSD 患者生活质量差的独立预测因素。需要进一步系统研究与残疾程度增加相关的因素。

方法

我们对五家大型 NMOSD 转诊中心的 NMOSD 患者进行了回顾性图表分析,这些患者的 AQP4 血清阳性,且有脊髓炎病史,全球有详细记录包括复发史和相应影像学资料。提取与长期残疾相关的潜在因素,包括人口统计学、影像学表现和临床特征。采用多变量回归模型确定 NMOSD 患者残疾的相关因素,用扩展残疾状况量表(EDSS)来衡量。

结果

本研究共纳入 182 例 AQP4 血清阳性患者(88%为女性)。多变量回归模型显示,发病年龄较大、诊断/预防治疗延迟、最长急性脊髓炎病灶长度和有症状性脑/脑干病灶与残疾程度增加有关,在其他变量不变的情况下。

结论

虽然发病年龄是 NMOSD 无法控制的因素,但我们可以减少诊断/预防治疗的延迟,并减少未来脑/脑干和脊髓的复发。诊断/预防治疗延迟和影像学变量与残疾程度增加有关,这支持需要改进 NMOSD 的早期、准确诊断和管理措施,并积极治疗急性复发。

相似文献

1
Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.视神经脊髓炎谱系疾病伴发脊髓炎病史的患者长期残疾与发病年龄、诊断/预防治疗延迟、MRI 病变长度和症状性脑病变存在有关。
Mult Scler Relat Disord. 2019 Feb;28:64-68. doi: 10.1016/j.msard.2018.12.011. Epub 2018 Dec 9.
2
Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.水通道蛋白-4 免疫球蛋白 G 阳性视神经脊髓炎谱系疾病中的短节段脊髓炎病变。
JAMA Neurol. 2015 Jan;72(1):81-7. doi: 10.1001/jamaneurol.2014.2137.
3
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder.迟发性视神经脊髓炎谱系障碍的临床特征
Mult Scler Relat Disord. 2023 Feb;70:104517. doi: 10.1016/j.msard.2023.104517. Epub 2023 Jan 15.
4
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.视神经脊髓炎及相关疾病中的髓鞘少突胶质细胞糖蛋白免疫球蛋白G:50例患者的多中心研究。第2部分:流行病学、临床表现、影像学和实验室特征、治疗反应及长期预后
J Neuroinflammation. 2016 Sep 27;13(1):280. doi: 10.1186/s12974-016-0718-0.
5
Short transverse myelitis in Chinese patients with neuromyelitis optica spectrum disorders.视神经脊髓炎谱系疾病中国患者的短节段横贯性脊髓炎。
Mult Scler Relat Disord. 2018 Apr;21:78-83. doi: 10.1016/j.msard.2018.02.022. Epub 2018 Feb 19.
6
Clinical characteristics of late-onset neuromyelitis optica spectrum disorder: A multicenter retrospective study in Korea.韩国多中心回顾性研究:晚发性视神经脊髓炎谱系疾病的临床特征。
Mult Scler. 2017 Nov;23(13):1748-1756. doi: 10.1177/1352458516685416. Epub 2017 Jan 6.
7
Correlations among disability, anti-AQP4 antibody status and prognosis in the spinal cord involved patients with NMOSD.视神经脊髓炎谱系疾病脊髓受累患者的残疾、抗水通道蛋白 4 抗体状态与预后的相关性。
BMC Neurol. 2021 Apr 9;21(1):153. doi: 10.1186/s12883-021-02171-2.
8
Age of onset correlates with clinical characteristics and prognostic outcomes in neuromyelitis optica spectrum disorder.发病年龄与视神经脊髓炎谱系疾病的临床特征和预后结局相关。
Front Immunol. 2022 Dec 8;13:1056944. doi: 10.3389/fimmu.2022.1056944. eCollection 2022.
9
[Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].视神经脊髓炎及视神经脊髓炎谱系障碍患儿的临床特征与随访
Zhonghua Er Ke Za Zhi. 2015 Apr;53(4):268-73.
10
The risk factors of neuropathic pain in neuromyelitis optica spectrum disorder: a retrospective case-cohort study.视神经脊髓炎谱系疾病中神经病理性疼痛的危险因素:一项回顾性病例队列研究。
BMC Neurol. 2022 Aug 19;22(1):304. doi: 10.1186/s12883-022-02841-9.

引用本文的文献

1
Aquaporin-4-positive neuromyelitis optica in a male Caucasian patient: A rare demographic presentation.一名男性白种人患者的水通道蛋白4阳性视神经脊髓炎:一种罕见的人口统计学表现。
SAGE Open Med Case Rep. 2025 Jul 8;13:2050313X251356911. doi: 10.1177/2050313X251356911. eCollection 2025.
2
Relapses during treatment with monoclonal antibodies targeting B-cells in NMOSD.视神经脊髓炎谱系疾病(NMOSD)中使用靶向B细胞的单克隆抗体治疗期间的复发情况。
J Neurol. 2025 May 18;272(6):406. doi: 10.1007/s00415-025-13118-9.
3
Clinical and immunological differences between primary and autoimmune-associated neuromyelitis optica spectrum disorders: a retrospective study.原发性与自身免疫相关的视神经脊髓炎谱系障碍的临床和免疫学差异:一项回顾性研究。
Lupus Sci Med. 2025 Apr 14;12(1):e001491. doi: 10.1136/lupus-2024-001491.
4
Comparison of treatment efficacy and cost-effectiveness of rituximab and oral agents among patients with neuromyelitis optica spectrum disorders: a population-based cohort study.视神经脊髓炎谱系障碍患者中利妥昔单抗与口服药物的治疗效果及成本效益比较:一项基于人群的队列研究
Ther Adv Neurol Disord. 2025 Feb 24;18:17562864251314020. doi: 10.1177/17562864251314020. eCollection 2025.
5
Combined Central and Peripheral Demyelination (CCPD) Associated with MOG Antibodies: Report of Four New Cases and Narrative Review of the Literature.与MOG抗体相关的中枢和周围联合脱髓鞘病变(CCPD):4例新病例报告及文献综述
J Clin Med. 2024 Jun 20;13(12):3604. doi: 10.3390/jcm13123604.
6
Moving towards a new era for the treatment of neuromyelitis optica spectrum disorders.迈向治疗视神经脊髓炎谱系疾病的新时代。
J Neurol. 2024 Jul;271(7):3879-3896. doi: 10.1007/s00415-024-12426-w. Epub 2024 May 21.
7
T1 hypointense brain lesions in NMOSD and its relevance with disability: a single institution cross-sectional study.NMOSD 中 T1 低信号脑病变及其与残疾的相关性:一项单机构横断面研究。
BMC Neurol. 2024 Feb 12;24(1):62. doi: 10.1186/s12883-024-03550-1.
8
Whole grains and legumes consumption in association with neuromyelitis optica spectrum disorder odds.全谷物和豆类的摄入与视神经脊髓炎谱系障碍几率的关系。
Curr J Neurol. 2021 Jul 6;20(3):131-138. doi: 10.18502/cjn.v20i3.7688.
9
Clinical features and visual prognosis of very late-onset neuromyelitis optica spectrum disorder-related optic neuritis.极晚发性视神经脊髓炎谱系疾病相关性视神经炎的临床特征和视觉预后。
Neurol Sci. 2024 May;45(5):2191-2197. doi: 10.1007/s10072-023-07187-9. Epub 2023 Nov 20.
10
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) - revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management.视神经脊髓炎谱系疾病(NMOSD)的诊断和治疗进展——视神经脊髓炎研究组(NEMOS)的修订建议。第二部分:发作期治疗和长期管理。
J Neurol. 2024 Jan;271(1):141-176. doi: 10.1007/s00415-023-11910-z. Epub 2023 Sep 7.

本文引用的文献

1
Vitamin D in the prevention, prediction and treatment of neurodegenerative and neuroinflammatory diseases.维生素D在神经退行性疾病和神经炎症性疾病的预防、预测及治疗中的作用
EPMA J. 2017 Nov 15;8(4):313-325. doi: 10.1007/s13167-017-0120-8. eCollection 2017 Dec.
2
Catastrophic relapses following initiation of dimethyl fumarate in two patients with neuromyelitis optica spectrum disorder.两名视神经脊髓炎谱系障碍患者在开始使用富马酸二甲酯后发生灾难性复发。
Mult Scler. 2017 Aug;23(9):1297-1300. doi: 10.1177/1352458517694086. Epub 2017 Apr 10.
3
Insufficient treatment of severe depression in neuromyelitis optica spectrum disorder.视神经脊髓炎谱系障碍中重度抑郁症的治疗不足。
Neurol Neuroimmunol Neuroinflamm. 2016 Oct 24;3(6):e286. doi: 10.1212/NXI.0000000000000286. eCollection 2016 Dec.
4
Early indicators of relapses vs pseudorelapses in neuromyelitis optica spectrum disorder.视神经脊髓炎谱系障碍中复发与假性复发的早期指标。
Neurol Neuroimmunol Neuroinflamm. 2016 Jul 28;3(5):e269. doi: 10.1212/NXI.0000000000000269. eCollection 2016 Oct.
5
Evaluation of the 2015 diagnostic criteria for neuromyelitis optica spectrum disorder.视神经脊髓炎谱系障碍2015年诊断标准的评估
Neurology. 2016 May 10;86(19):1772-9. doi: 10.1212/WNL.0000000000002655. Epub 2016 Apr 13.
6
Immunopathology: autoimmune glial diseases and differentiation from multiple sclerosis.免疫病理学:自身免疫性胶质疾病及其与多发性硬化症的鉴别
Handb Clin Neurol. 2016;133:95-106. doi: 10.1016/B978-0-444-63432-0.00006-2.
7
Factors that impact health-related quality of life in neuromyelitis optica spectrum disorder: anxiety, disability, fatigue and depression.视神经脊髓炎谱系障碍中影响健康相关生活质量的因素:焦虑、残疾、疲劳和抑郁。
J Neuroimmunol. 2016 Apr 15;293:54-58. doi: 10.1016/j.jneuroim.2016.02.011. Epub 2016 Feb 16.
8
Treatment of Neuromyelitis Optica Spectrum Disorder: Acute, Preventive, and Symptomatic.视神经脊髓炎谱系疾病的治疗:急性、预防和对症。
Curr Treat Options Neurol. 2016 Jan;18(1):2. doi: 10.1007/s11940-015-0387-9.
9
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.视神经脊髓炎:871 次发作和 1153 次治疗过程评估。
Ann Neurol. 2016 Feb;79(2):206-16. doi: 10.1002/ana.24554. Epub 2015 Nov 26.
10
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.视神经脊髓炎谱系障碍国际共识诊断标准
Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212/WNL.0000000000001729. Epub 2015 Jun 19.